Schedule 13G ownership disclosure

Aligos Therapeutics Inc

Voting Common Stock, par value $0.0001 per share · CUSIP: 01626L204

Event date: 2025-12-31

Filing-level shares
289,169.00
Percent of class
5.4%
  • Woodline Partners LP

    Shares: 289,169.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001065
Form type
SCHEDULE 13G/A
Filer
Aligos Therapeutics, Inc.
CIK
CIK 1799448
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub